Abstract

Thrombosis is a recognized complication of Hodgkin's disease. The mechanism for thrombosis in this setting is not known. We determined the functional expression of tissue factor on peripheral blood monocytes in 14 consecutive patients with relapsed Hodgkin's disease. Marked elevations in activity were present in slightly more than half of the subjects. Tissue factor activities varied over 75-fold. Patients with higher tissue factor levels tended to be males who had not undergone splenectomy as part of their staging evaluation. Definite thrombotic complications occurred in three of the patients with the highest levels of tissue factor. While monocyte tissue factor may play a contributory role in the development of thrombotic complications in some patients with relapsed Hodgkin's disease, marked elevation of tissue factor is characteristic of only a subpopulation of these patients. This suggests that patient-, therapy- or disease-specific variables, including tissue factor, may determine the development of thrombosis in these patients.

Original languageEnglish (US)
Pages (from-to)259-263
Number of pages5
JournalLeukemia and Lymphoma
Volume12
Issue number3-4
DOIs
StatePublished - Jan 1 1994

Fingerprint

Thromboplastin
Hodgkin Disease
Monocytes
Thrombosis
Splenectomy

Keywords

  • Hodgkin's disease
  • Monocyte tissue factor

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Monocyte tissue factor in treated hodgkin's disease. / Haire, William D.; Carson, Steven D; Pirruccello, Samuel Jay.

In: Leukemia and Lymphoma, Vol. 12, No. 3-4, 01.01.1994, p. 259-263.

Research output: Contribution to journalArticle

@article{6e17d2f3265a49768edb79d46021edcb,
title = "Monocyte tissue factor in treated hodgkin's disease",
abstract = "Thrombosis is a recognized complication of Hodgkin's disease. The mechanism for thrombosis in this setting is not known. We determined the functional expression of tissue factor on peripheral blood monocytes in 14 consecutive patients with relapsed Hodgkin's disease. Marked elevations in activity were present in slightly more than half of the subjects. Tissue factor activities varied over 75-fold. Patients with higher tissue factor levels tended to be males who had not undergone splenectomy as part of their staging evaluation. Definite thrombotic complications occurred in three of the patients with the highest levels of tissue factor. While monocyte tissue factor may play a contributory role in the development of thrombotic complications in some patients with relapsed Hodgkin's disease, marked elevation of tissue factor is characteristic of only a subpopulation of these patients. This suggests that patient-, therapy- or disease-specific variables, including tissue factor, may determine the development of thrombosis in these patients.",
keywords = "Hodgkin's disease, Monocyte tissue factor",
author = "Haire, {William D.} and Carson, {Steven D} and Pirruccello, {Samuel Jay}",
year = "1994",
month = "1",
day = "1",
doi = "10.3109/10428199409059597",
language = "English (US)",
volume = "12",
pages = "259--263",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "3-4",

}

TY - JOUR

T1 - Monocyte tissue factor in treated hodgkin's disease

AU - Haire, William D.

AU - Carson, Steven D

AU - Pirruccello, Samuel Jay

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Thrombosis is a recognized complication of Hodgkin's disease. The mechanism for thrombosis in this setting is not known. We determined the functional expression of tissue factor on peripheral blood monocytes in 14 consecutive patients with relapsed Hodgkin's disease. Marked elevations in activity were present in slightly more than half of the subjects. Tissue factor activities varied over 75-fold. Patients with higher tissue factor levels tended to be males who had not undergone splenectomy as part of their staging evaluation. Definite thrombotic complications occurred in three of the patients with the highest levels of tissue factor. While monocyte tissue factor may play a contributory role in the development of thrombotic complications in some patients with relapsed Hodgkin's disease, marked elevation of tissue factor is characteristic of only a subpopulation of these patients. This suggests that patient-, therapy- or disease-specific variables, including tissue factor, may determine the development of thrombosis in these patients.

AB - Thrombosis is a recognized complication of Hodgkin's disease. The mechanism for thrombosis in this setting is not known. We determined the functional expression of tissue factor on peripheral blood monocytes in 14 consecutive patients with relapsed Hodgkin's disease. Marked elevations in activity were present in slightly more than half of the subjects. Tissue factor activities varied over 75-fold. Patients with higher tissue factor levels tended to be males who had not undergone splenectomy as part of their staging evaluation. Definite thrombotic complications occurred in three of the patients with the highest levels of tissue factor. While monocyte tissue factor may play a contributory role in the development of thrombotic complications in some patients with relapsed Hodgkin's disease, marked elevation of tissue factor is characteristic of only a subpopulation of these patients. This suggests that patient-, therapy- or disease-specific variables, including tissue factor, may determine the development of thrombosis in these patients.

KW - Hodgkin's disease

KW - Monocyte tissue factor

UR - http://www.scopus.com/inward/record.url?scp=0028231244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028231244&partnerID=8YFLogxK

U2 - 10.3109/10428199409059597

DO - 10.3109/10428199409059597

M3 - Article

VL - 12

SP - 259

EP - 263

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3-4

ER -